Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Moore

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
International Journal of Endocrinology|January 6, 2010
Vitamin d pathway genes, diet, and risk of renal cell carcinomaS Karami, P Brennan, M Navratilova, et al.
British Journal of Cancer|May 5, 2011
Occupational exposure to dusts and risk of renal cell carcinomaS Karami, P Boffetta, P S Stewart, et al.
Occupational and Environmental Medicine|September 10, 2009
Occupation and renal cell cancer in Central and Eastern EuropeJ E Heck, B Charbotel, L E Moore, et al.
Carcinogenesis|June 21, 2008
Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphismsS Karami, P Boffetta, N Rothman, et al.
Carcinogenesis|July 10, 2007
Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer StudyL E Moore, P Brennan, S Karami, et al.
Journal of Toxicology and Environmental Health. Part A|February 5, 2008
Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern EuropeS Karami, P Brennan, R J Hung, et al.
Cancer Letters|February 9, 2010
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern EuropeK Szymańska, L E Moore, N Rothman, et al.
Carcinogenesis|November 2, 2010
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysisL E Moore, D R Baris, J D Figueroa, et al.
Oncogenesis|April 5, 2013
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationL E Moore, E Jaeger, M L Nickerson, et al.
Oncogene|November 8, 2016
TET2 binds the androgen receptor and loss is associated with prostate cancerM L Nickerson, S Das, K M Im, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
International Journal of Endocrinology|January 6, 2010
Vitamin d pathway genes, diet, and risk of renal cell carcinomaS Karami, P Brennan, M Navratilova, et al.
British Journal of Cancer|May 5, 2011
Occupational exposure to dusts and risk of renal cell carcinomaS Karami, P Boffetta, P S Stewart, et al.
Occupational and Environmental Medicine|September 10, 2009
Occupation and renal cell cancer in Central and Eastern EuropeJ E Heck, B Charbotel, L E Moore, et al.
Carcinogenesis|June 21, 2008
Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphismsS Karami, P Boffetta, N Rothman, et al.
Carcinogenesis|July 10, 2007
Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer StudyL E Moore, P Brennan, S Karami, et al.
Journal of Toxicology and Environmental Health. Part A|February 5, 2008
Vitamin D receptor polymorphisms and renal cancer risk in Central and Eastern EuropeS Karami, P Brennan, R J Hung, et al.
Cancer Letters|February 9, 2010
TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern EuropeK Szymańska, L E Moore, N Rothman, et al.
Carcinogenesis|November 2, 2010
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysisL E Moore, D R Baris, J D Figueroa, et al.
Oncogenesis|April 5, 2013
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivationL E Moore, E Jaeger, M L Nickerson, et al.
Oncogene|November 8, 2016
TET2 binds the androgen receptor and loss is associated with prostate cancerM L Nickerson, S Das, K M Im, et al.
Pageof 12